PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
6,992,647
Share change
-4,135,300
Total reported value
$4,631,653
Price per share
$0.66
Number of holders
34
Value change
-$2,731,024
Number of buys
10
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q4 2017

As of 31 Dec 2017, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,992,647 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Opaleye Management Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, HIGHBRIDGE CAPITAL MANAGEMENT LLC, UBS OCONNOR LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, FEDERATED INVESTORS INC /PA/, MEITAV DASH INVESTMENTS LTD, MORGAN STANLEY, and MACQUARIE GROUP LTD. This page lists 34 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.